Sleep and physical activity measured by accelerometry in Crohn's disease

Alimentary Pharmacology and Therapeutics

Volumn 41, Issue 10, 2015, Pages 991-1004

  Van Langenberg, D R ^a   Papandony, M C ^a   Gibson, P R ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; COLECALCIFEROL; HEMOGLOBIN; TUMOR NECROSIS FACTOR ALPHA;

ACCELEROMETRY; ADULT; AGED; AROUSAL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FATIGUE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MALE; PATIENT ASSESSMENT; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SELF REPORT; SITTING; SLEEP DISORDER; SLEEP QUALITY; SLEEP TIME; VITAMIN BLOOD LEVEL; ANTAGONISTS AND INHIBITORS; CASE CONTROL STUDY; COMPLICATION; CROSS-SECTIONAL STUDY; MIDDLE AGED; MOTOR ACTIVITY; PHYSIOLOGY; SLEEP; YOUNG ADULT;

ACCELEROMETRY; ADULT; AGED; CASE-CONTROL STUDIES; CROHN DISEASE; CROSS-SECTIONAL STUDIES; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR ACTIVITY; SELF REPORT; SLEEP; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84927731527     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13160     Document Type: Article

References (47)

1. van Langenberg DR, Gibson PR,. Systematic review: fatigue in inflammatory bowel disease. Aliment Pharmacol Ther 2010; 32: 131-43.
2. Ali T, Orr WC,. Sleep disturbances and inflammatory bowel disease. Inflamm Bowel Dis 2014; 20: 1986-95.
3. Keefer L, Stepanski EJ, Ranjbaran Z, et al,. An initial report of sleep disturbance in inactive inflammatory bowel disease. J Clin Sleep Med 2006; 2: 409-16.
4. Ranjbaran Z, Keefer L, Farhadi A, et al,. Impact of sleep disturbances in inflammatory bowel disease. J Gastroenterol Hepatol 2007; 22: 1748-53.
5. Fass R, Fullerton S, Tung S, et al,. Sleep disturbances in clinic patients with functional bowel disorders. Am J Gastroenterol 2000; 95: 1195-2000.
6. Goldsmith G, Levin JS,. Effect of sleep quality on symptoms of irritable bowel syndrome. Dig Dis Sci 1993; 38: 1809-14.
7. Kanaly T, Shaheen NJ, Vaughn BV,. Gastrointestinal physiology and digestive disorders in sleep. Curr Opin Pulm Med 2009; 15: 571-7.
8. Orr WC,. Sleep and gastrointestinal disease: a new horizon in sleep medicine. Sleep Med 2009; 10: 595-6.
9. van Langenberg DR, Gibson PR,. Factors associated with physical and cognitive fatigue in patients with Crohn's disease: a cross-sectional and longitudinal study. Inflamm Bowel Dis 2014; 20: 115-25.
10. Simren M, Svedlund J, Posserud I, et al,. Predictors of subjective fatigue in chronic gastrointestinal disease. Aliment Pharmacol Ther 2008; 28: 638-47.
11. Graff LA, Vincent N, Walker JR, et al,. A population-based study of fatigue and sleep difficulties in inflammatory bowel disease. Inflamm Bowel Dis 2011; 17: 1882-9.
12. Jelsness-Jorgensen LP, Bernklev T, Henriksen M, et al,. Chronic fatigue is more prevalent in patients with inflammatory bowel disease than in healthy controls. Inflamm Bowel Dis 2011; 17: 1564-72.
13. Kriska AM, Saremi A, Hanson RL, et al,. Physical activity, obesity, and the incidence of type 2 diabetes in a high-risk population. Am J Epidemiol 2003; 158: 669-75.
14. Ponsonby AL, Sun C, Ukoumunne OC, et al,. Objectively measured physical activity and the subsequent risk of incident dysglycemia: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Diabetes Care 2011; 34: 1497-502.
15. Qin L, Knol MJ, Corpeleijn E, et al,. Does physical activity modify the risk of obesity for type 2 diabetes: a review of epidemiological data. Eur J Epidemiol 2010; 25: 5-12.
16. Bryant RV, Trott MJ, Bartholomeusz FD, et al,. Systematic review: body composition in adults with inflammatory bowel disease. Aliment Pharmacol Ther 2013; 38: 213-25.
17. de Souza L, Benedito-Silva AA, Pires ML, et al,. Further validation of actigraphy for sleep studies. Sleep 2003; 26: 81-5.
18. Sadeh A,. The role and validity of actigraphy in sleep medicine: an update. Sleep Med Rev 2011; 15: 259-67.
19. Buysse DJ, Reynolds CF 3rd, Monk TH, et al,. Quantification of subjective sleep quality in healthy elderly men and women using the Pittsburgh Sleep Quality Index (PSQI). Sleep 1991; 14: 331-8.
20. Beck SL, Schwartz AL, Towsley G, et al,. Psychometric evaluation of the Pittsburgh Sleep Quality Index in cancer patients. J Pain Symptom Manage 2004; 27: 140-8.
21. Rush AJ, First MB, Blacker D, et al,. Handbook of Psychiatric Measures. Washington, DC: American Psychiatric Publishing, 2008.
22. Fisk JD, Ritvo PG, Ross L, et al,. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis 1994; 18 (Suppl. 1): S79-83.
23. Zigmond AS, Snaith RP,. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-70.
24. Kalaitzakis E, Carlsson E, Josefsson A, et al,. Quality of life in short-bowel syndrome: impact of fatigue and gastrointestinal symptoms. Scand J Gastroenterol 2008; 43: 1057-65.
25. Harvey RF, Bradshaw JM,. A simple index of Crohn's-disease activity. Lancet 1980; 1: 514.
26. Actigraph. GT3X Activity monitor. Vol. 2011 (Pensacola, Florida 2011).
27. Sadeh A, Hauri PJ, Kripke DF, et al,. The role of actigraphy in the evaluation of sleep disorders. Sleep 1995; 18: 288-302.
28. Sadeh A, Sharkey KM, Carskadon MA,. Activity-based sleep-wake identification: an empirical test of methodological issues. Sleep 1994; 17: 201-7.
29. Bar-Or D, Rael LT, Lau EP, et al,. An analog of the human albumin N-terminus (Asp-Ala-His-Lys) prevents formation of copper-induced reactive oxygen species. Biochem Biophys Res Commun 2001; 284: 856-62.
30. Kirk EP, Washburn RA, Bailey BW, et al,. Six months of supervised high-intensity low-volume resistance training improves strength independent of changes in muscle mass in young overweight men. J Strength Cond Res 2007; 21: 151-6.
31. Scheers T, Philippaerts R, Lefevre J,. Objectively-determined intensity- and domain-specific physical activity and sedentary behavior in relation to percent body fat. Clin Nutr 2013; 32: 999-1006.
32. Gebel K, Ding D, Bauman AE,. Volume and intensity of physical activity in a large population-based cohort of middle-aged and older Australians: prospective relationships with weight gain, and physical function. Prev Med 2014; 60: 131-3.
33. Rognmo O, Moholdt T, Bakken H, et al,. Cardiovascular risk of high- versus moderate-intensity aerobic exercise in coronary heart disease patients. Circulation 2012; 126: 1436-40.
34. Yarur AJ, Deshpande AR, Pechman DM, et al,. Inflammatory bowel disease is associated with an increased incidence of cardiovascular events. Am J Gastroenterol 2011; 106: 741-7.
35. Bilski J, Brzozowski B, Mazur-Bialy A, et al,. The role of physical exercise in inflammatory bowel disease. Biomed Res Int 2014; 2014: 429031.
36. D'Inca R, Varnier M, D'Odorico A, et al,. Exercise and inflammatory bowel disease: immunological aspects. Exerc Immunol Rev 2000; 6: 43-53.
37. van Langenberg DR, Della Gatta P, Warmington SA, et al,. Objectively measured muscle fatigue in Crohn's disease: correlation with self-reported fatigue and associated factors for clinical application. J Crohns Colitis 2014; 8: 137-46.
38. Rotem AY, Sperber AD, Krugliak P, et al,. Polysomnographic and actigraphic evidence of sleep fragmentation in patients with irritable bowel syndrome. Sleep 2003; 26: 747-52.
39. Ali T, Madhoun MF, Orr WC, et al,. Assessment of the relationship between quality of sleep and disease activity in inflammatory bowel disease patients. Inflamm Bowel Dis 2013; 19: 2440-3.
40. Benz RL, Pressman MR, Hovick ET, et al,. A preliminary study of the effects of correction of anemia with recombinant human erythropoietin therapy on sleep, sleep disorders, and daytime sleepiness in hemodialysis patients (The SLEEPO study). Am J Kidney Dis 1999; 34: 1089-95.
41. Walker JM, Farney RJ, Rhondeau SM, et al,. Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing. J Clin Sleep Med 2007; 3: 455-61.
42. Cronin A, Keifer JC, Baghdoyan HA, et al,. Opioid inhibition of rapid eye movement sleep by a specific mu receptor agonist. Br J Anaesth 1995; 74: 188-92.
43. Yngve A, Nilsson A, Sjostrom M, et al,. Effect of monitor placement and of activity setting on the MTI accelerometer output. Med Sci Sports Exerc 2003; 35: 320-6.
44. Sirard JR, Melanson EL, Li L, et al,. Field evaluation of the Computer Science and Applications, Inc. physical activity monitor. Med Sci Sports Exerc 2000; 32: 695-700.
45. Jean-Louis G, Kripke DF, Cole RJ, et al,. Sleep detection with an accelerometer actigraph: comparisons with polysomnography. Physiol Behav 2001; 72: 21-8.
46. Freedson PS, Melanson E, Sirard J,. Calibration of the Computer Science and Applications, Inc. accelerometer. Med Sci Sports Exerc 1998; 30: 777-81.
47. Ainsworth BE, Haskell WL, Herrmann SD, et al,. 2011 Compendium of Physical Activities: a second update of codes and MET values. Med Sci Sports Exerc 2011; 43: 1575-81.